Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey

被引:2
|
作者
Gebrehiwet, Paulos [1 ,5 ]
Brekke, Johan [2 ]
Rudnicki, Stacy A. [3 ]
Mellor, Jennifer [4 ]
Wright, Jack [4 ]
Earl, Lucy [4 ]
Ball, Nathan [4 ]
Iqbal, Halima [4 ]
Thomas, Owen [4 ]
Castellano, Giorgio [4 ]
机构
[1] Cytokinetics Inc, Hlth Econ & Outcomes Res, South San Francisco, CA USA
[2] Cytokinetics Inc, Med Affairs, South San Francisco, CA USA
[3] Cytokinetics Inc, Clin Res, South San Francisco, CA USA
[4] Adelphi Real World, Real World Evidence, Bollington, England
[5] Cytokinetics Inc, Hlth Econ & Outcomes Res, 350 Oyster Point Blvd, South San Francisco, CA 94080 USA
关键词
Amyotrophic lateral sclerosis; clinical milestones; progression; multinational; ALS; BODY-MASS INDEX; STAGING SYSTEM; ALSFRS-R; PROGRESSION; SURVIVAL; DIAGNOSIS; EPIDEMIOLOGY; PROGNOSIS; PATIENT; RISK;
D O I
10.1080/21678421.2023.2297795
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveTo determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defined milestones, overall and according to ALS progression rate and geographic location.MethodsData were drawn from the Adelphi Real World ALS Disease-Specific ProgrammeTM, a point-in-time survey of neurologists caring for people living with ALS (pALS) conducted in France, Germany, Italy, Spain, the United Kingdom and the United States from 2020-2021. ALS progression rate was calculated using time since symptom onset and ALS Functional Rating Scale Revised score.ResultsSurvey results were available for N = 1003 pALS (progression rate for N = 867). Mean time from symptom onset was 3.8 months to first consultation, 8.0 months to diagnosis, 16.2 months to employment change (part-time/sick leave/retirement/unemployment), 17.5 months to use of a walking aid, 18.5 months to first occurrence of caregiver support, 22.8 months to use of a wheelchair, 24.6 months to use of a communication aid, 27.3 months to use of a respiratory aid, 28.6 months to use of gastrostomy feeding, 29.7 months to use of eye gaze technology and 30.3 months to entering a care facility. Multivariate analysis indicated significant effects of fast (versus slow) progression rate on time to reach all 11 milestones, as well as US (versus European) location, age, body mass index and bulbar onset (versus other) on time to reach milestones.ConclusionspALS rapidly reached clinical and disease-related milestones within 30 months from symptom onset. Milestones were reached significantly faster by pALS with fast versus slow progression. Geographic differences were observed.
引用
收藏
页码:345 / 357
页数:13
相关论文
共 50 条
  • [41] Dissociation of disease onset, progression and sex differences from androgen receptor levels in a mouse model of amyotrophic lateral sclerosis
    Doris Tomas
    Victoria M. McLeod
    Mathew D. F. Chiam
    Nayomi Wanniarachchillage
    Wah C. Boon
    Bradley J. Turner
    Scientific Reports, 11
  • [42] Transportation assimilation revisited: New evidence from repeated cross-sectional survey data
    Xu, Dafeng
    PLOS ONE, 2018, 13 (04):
  • [43] Estimation of age-specific incidence rates from cross-sectional survey data
    Roy, Jason
    Stewart, Walter F.
    STATISTICS IN MEDICINE, 2010, 29 (05) : 588 - 596
  • [44] Statistical methods for estimating incidence and remission rates from cross-sectional survey data
    Roy, J.
    Stewart, W.
    Lipton, R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S110 - S110
  • [45] The relationship between the built environment and subjective wellbeing - Analysis of cross-sectional data from the English Housing Survey
    Huebner, Gesche M.
    Oreszczyn, Tadj
    Direk, Kenan
    Hamilton, Ian
    JOURNAL OF ENVIRONMENTAL PSYCHOLOGY, 2022, 80
  • [46] SOCIODEMOGRAPHIC VARIATIONS IN PSA SCREENING USE: A CROSS-SECTIONAL ANALYSIS OF DATA FROM THE NATIONAL HEALTH INTERVIEW SURVEY
    Maki, K.
    Tan, N. Q. P.
    Volk, R. J.
    VALUE IN HEALTH, 2023, 26 (06) : S257 - S257
  • [47] TREATMENT-RELATED AND NON-TREATMENT-RELATED OUT-OF-POCKET COSTS BY AMYOTROPHIC LATERAL SCLEROSIS DISEASE STAGE: A CROSS-SECTIONAL PATIENT SURVEY AND RETROSPECTIVE CHART REVIEW
    Ploug, U.
    Savic, N.
    Mellor, J.
    Wright, J.
    Bonar, K.
    VALUE IN HEALTH, 2022, 25 (12) : S157 - S157
  • [48] Preliminary cross-sectional structural MRI analysis of data from the Alzheimer's disease neuroimaging initiative
    Fennema-Notestine, Christine
    Fleisher, Adam S.
    Hagler, Donald J., Jr.
    Wu, Elaine H.
    Karow, David S.
    Dale, Anders M.
    NEUROLOGY, 2007, 68 (12) : A235 - A235
  • [49] Information on Cardiovascular Disease in the Digital Era: Results From a Cross-Sectional Patient Survey
    Coomes, Eric A.
    Haghbayan, Hourmazd
    Finken, Laura R.
    Quadros, Kenneth K.
    Bagai, Akshay
    Cheema, Asim N.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (06) : 791 - 794
  • [50] Epidemiology of chronic airway disease: results from a cross-sectional survey in Beijing, China
    Zhang, Hong
    Dong, Li
    Kang, Yi-Kun
    Lu, Yong
    Wei, Hui-Hong
    Huang, Jie
    Wang, Xue
    Huang, Kewu
    JOURNAL OF THORACIC DISEASE, 2018, 10 (11) : 6168 - 6175